5-(2-Carboxy-ethylmercapto)-valeriansaeure | 90114-00-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 5-(2-Carboxy-ethylmercapto)-valeriansaeure
• 英文别名: 4-Carboxybutyl 2-carboxyethyl sulfide；5-(2-carboxyethylsulfanyl)pentanoic acid
• CAS: 90114-00-4
• 化学式: C₈H₁₄O₄S
• 分子量: 206.263
• InChiKey: BUEUOGUFHBHUDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  99.9
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-(2-Carboxy-ethylmercapto)-valeriansaeure 在 双氧水 作用下， 以 丙酮 为溶剂， 生成 5-(2-Carboxy-ethylsulfin)-valeriansaeure
  参考文献：
  名称：

  Allenmark,S., Acta Chemica Scandinavica (1947), 1963, vol. 17, p. 2711 - 2714

  摘要：

  DOI：
• 作为产物：
  描述：

  5-巯基戊酸乙酯 在 五羰基铁 作用下， 生成 5-(2-Carboxy-ethylmercapto)-valeriansaeure
  参考文献：
  名称：

  Synthesis of unsymmetrical sulfides containing functional groups

  摘要：

  DOI：

  10.1007/bf00907486

文献信息

• Addition, substitution, and telomerization reactions of olefins in the presence of metal carbonyls or colloidal iron
  作者：A.N. Nesmeyanov、R.Kh. Freidlina、E.C. Chukovskaya、R.G. Petrova、A.B. Belyavsky

  DOI：10.1016/s0040-4020(01)99004-0

  日期：1962.1
• METHODS FOR INHIBITING PROLIFERATION AND INDUCING APOPTOSIS IN CANCER CELLS
  申请人：CREIGHTON UNIVERSITY

  公开号：EP1326605A1

  公开（公告）日：2003-07-16
• EP1326605A4
  申请人：——

  公开号：EP1326605A4

  公开（公告）日：2004-03-17
• [EN] METHODS FOR INHIBITING PROLIFERATION AND INDUCING APOPTOSIS IN CANCER CELLS<br/>[FR] PROCEDES SERVANT A INHIBER LA PROLIFERATION ET A INDUIRE L'APOPTOSE DANS DES CELLULES CANCEREUSES
  申请人：UNIV CREIGHTON

  公开号：WO2001085166A1

  公开（公告）日：2001-11-15

  Disclosed are methods of decreasing proliferation of adenocarcinoma cancer cells, or of inducing apoptosis of adenocarcinoma cancer cells, or of inducing differentiation of adenocarcinoma cancer cells into non-cancerous cells. One such method includes contacting the adenocarcinoma cancer cells with a compound under conditions effective for the compound to inhibit binding of leukotriene B4 to leukotriene B4 receptor. In another such method, the method includes contacting the adenocarcinoma cancer cells with 2-(2-propyl-3-(3-(2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy)propoxy)phenoxy)benzoic acid or a pharmaceutically acceptable salt, solvate, or congener thereof. Also disclosed are methods of treating adenocarcinomas in a subject. One method includes administering to the subject an amount of a compound effective to inhibit binding of leukotriene B4 to leukotriene B4 receptor. Another method includes administering 2-(2-propyl-3-(3-(2-ethyl-4-(4-fluoropheyl)-5-hydroxyphenoxy)propoxy)phenoxy)benzoic acid or a pharmaceutically acceptable salt, solvate, or congener thereof, to the subject.